ROBERT JEREMY LANINGHAM MD NPI 1700973682

NPI Details

Robert Jeremy Laningham, MD is a family medicine in Conroe, TX with 29 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. Robert Jeremy Laningham, MD NPI is 1700973682. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS MEDICAL SCHOOL AT HOUSTON
Graduation Year:1996

The provider's business location address is:

4015 INTERSTATE 45 N STE 220
CONROE, TX
ZIP 77304-076
Phone: (936) 441-1122
Fax: (936) 788-9151

The NPI 1700973682 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Hemoglobin a1c level (HCPCS:83036)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Vitamin d-3 level (HCPCS:82306)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Identification of organisms by genetic analysis, amplified probe technique (HCPCS:87150)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Annual alcohol misuse screening, 15 minutes (HCPCS:G0442)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Urinalysis, manual test (HCPCS:81002)
• Testosterone (hormone) level, total (HCPCS:84403)
• Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes (HCPCS:G0446)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Face-to-face behavioral counseling for obesity, 15 minutes (HCPCS:G0447)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Removal of impacted ear wax (HCPCS:69210)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Destruction of precancer skin growth, 15 or more growths (HCPCS:17004)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 10/10/2006 and was last updated on 4/4/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: